XML 61 R43.htm IDEA: XBRL DOCUMENT v3.25.4
SHARE-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Expense Recognized in Connection with Share Based Awards
The following table presents the impact of share-based compensation expense for the years ended December 31.
(In millions, except for per-share amounts)202520242023
Impact on earnings from continuing operations$82 $72 $79 
Impact on earnings before income taxes82 72 79 
Impact on net earnings65 57 62 
Impact on net earnings per share:
Basic$.12 $.10 $.10 
Diluted.12 .10 .10 
Schedule of Share-based Compensation, Stock Options, Activity
The following tables summarize stock option activity under the employee stock option plan. There were no options granted in 2025, 2024 or 2023.
(In thousands of shares)Stock
Option
Shares		Weighted-Average
Exercise Price
Per Share
Outstanding at December 31, 20221,577 $32.05 
Granted in 20230 0.00 
Canceled in 20230 24.75 
Exercised in 2023(526)30.35 
Outstanding at December 31, 20231,051 32.90 
Granted in 20240 0.00 
Canceled in 2024(3)31.21 
Exercised in 2024(425)31.40 
Outstanding at December 31, 2024623 33.92 
Granted in 20250 0.00 
Canceled in 2025(2)30.53 
Exercised in 2025(301)31.04 
Outstanding at December 31, 2025320 $36.65 
Schedule of Cash Proceeds Received from Share-based Payment Awards
(In millions)202520242023
Total intrinsic value of options exercised$23 $25 $22 
Cash received from options exercised9 13 16 
Tax benefit realized as a result of options exercised and
  restricted stock releases		31 28 20 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable
(In thousands of shares)202520242023
Shares exercisable, end of year320 623 1,051 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table presents the assumptions used in valuing options granted, if applicable, during the years ended December 31.
202520242023
Expected term (years)8.08.08.0
Expected volatility27.2 %26.8 %26.7 %
Annual forfeiture rate4.4 4.4 4.2 
Risk-free interest rate4.2 4.0 3.0 
Dividend yield2.2 2.4 2.3 
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
The following table summarizes information about stock options outstanding and exercisable at December 31, 2025.
(In thousands of shares)Options OutstandingOptions Exercisable
Range of
Exercise Prices
Per Share		Stock Option
Shares
Outstanding		Wgtd.-Avg.
Remaining
Contractual
Life (Yrs.)		Wgtd.-Avg.
Exercise
Price
Per Share		Stock Option
Shares
Exercisable		Wgtd.-Avg.
Exercise
Price
Per Share
$0.00 -$28.97 39 0.1$28.97 39 $28.97 
28.97 -36.21 166 1.235.17 166 35.17 
36.21 -44.59 115 1.941.37 115 41.37 
$0.00 -$44.59 320 1.3$36.65 320 $36.65 
Schedule of Share-based Payment Award, Performance Based Restricted Stock, Valuation Assumptions
Key assumptions used to value performance-based restricted stock granted during 2025 follows:
(In millions)2025
Expected volatility (based on Aflac Inc. and peer group historical daily stock price) 21.3 %
Expected life from grant date (years)2.9
Risk-free interest rate (based on U.S. Treasury yields at the date of grant)4.2 %
Schedule of Nonvested Restricted Stock Units Activity
The value of restricted stock is based on the fair market value of the Company's common stock at the date of grant. The following table summarizes restricted stock activity during the years ended December 31. 
(In thousands of shares)SharesWeighted-Average
Grant-Date
Fair Value
Per  Share
Restricted stock at December 31, 20222,414 $56.21 
Granted in 20231,171 70.74 
Canceled in 2023(112)60.62 
Vested in 2023(1,165)52.77 
Restricted stock at December 31, 20232,308 62.96 
Granted in 20241,300 80.90 
Canceled in 2024(48)74.68 
Vested in 2024(1,461)47.22 
Restricted stock at December 31, 20242,099 73.65 
Granted in 20251,139 104.53 
Canceled in 2025(77)78.60 
Vested in 2025(1,294)68.83 
Restricted stock at December 31, 20251,867 $86.15